Terms: = Lymphoma AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7 AND Treatment
3140 results:
1. Advancements in cancer immunotherapies targeting cd20: from pioneering monoclonal antibodies to chimeric antigen receptor-modified T cells.
Dabkowska A; Domka K; Firczuk M
Front Immunol; 2024; 15():1363102. PubMed ID: 38638442
[TBL] [Abstract] [Full Text] [Related]
2. Primary cutaneous anaplastic large-cell lymphoma resembling infratemporal space infection: a case report.
Yan X; Ren W; Li S; Zhu Z; Gao L; Zhi K
BMC Oral Health; 2024 Apr; 24(1):470. PubMed ID: 38637781
[TBL] [Abstract] [Full Text] [Related]
3. Efficacy and Nuances of Precision Molecular Engineering for Hodgkin's Disease to a Gene Therapeutic Approach.
Qadir MI; Ahmed B; Hussain N
Crit Rev Immunol; 2024; 44(5):41-50. PubMed ID: 38618727
[TBL] [Abstract] [Full Text] [Related]
4. Empowering macrophages: the cancer fighters within the tumour microenvironment in mantle cell lymphoma.
Nylund P; Nikkarinen A; Ek S; Glimelius I
Front Immunol; 2024; 15():1373269. PubMed ID: 38566987
[TBL] [Abstract] [Full Text] [Related]
5. Establishment of cluster of differentiation 20 immobilized cell membrane chromatography for the screening of active antitumor components in traditional Chinese medicine.
Ding Y; Guo N; Jiang Y; Liu S; Zhou T; Bai H; Lv Y; Han S; He L
J Chromatogr A; 2024 Apr; 1721():464845. PubMed ID: 38552371
[TBL] [Abstract] [Full Text] [Related]
6. Investigator choice of standard therapy versus sequential novel therapy arms in the treatment of relapsed follicular lymphoma (REFRACT): study protocol for a multi-centre, open-label, randomised, phase II platform trial.
McIlroy G; Lax S; Gaskell C; Jackson A; Rhodes M; Seale T; Fox S; Hopkins L; Okosun J; Barrington SF; Ringshausen I; Ramsay AG; Calaminici M; Linton K; Bishton M
BMC Cancer; 2024 Mar; 24(1):370. PubMed ID: 38528445
[TBL] [Abstract] [Full Text] [Related]
7. [Studies on clinicopathological features of duodenal-type follicular lymphoma of 18 patients].
Du YR; Li J; Li SX; Guan CY; Li HL; Gao ZF; Li X; Dong GH
Zhonghua Xue Ye Xue Za Zhi; 2024 Jan; 45(1):94-97. PubMed ID: 38527846
[TBL] [Abstract] [Full Text] [Related]
8. Molecular assessment of intratumoral immune cell subsets and potential mechanisms of resistance to odronextamab, a cd20×CD3 bispecific antibody, in patients with relapsed/refractory B-cell non-Hodgkin lymphoma.
Brouwer-Visser J; Fiaschi N; Deering RP; Cygan KJ; Scott D; Jeong S; Boucher L; Gupta NT; Gupta S; Adler C; Topp MS; Bannerji R; Duell J; Advani RH; Flink DM; Chaudhry A; Thurston G; Ambati SR; Jankovic V
J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38519055
[TBL] [Abstract] [Full Text] [Related]
9. Repurposing of rituximab biosimilars to treat B cell mediated autoimmune diseases.
Mostkowska A; Rousseau G; Raynal NJ
FASEB J; 2024 Mar; 38(5):e23536. PubMed ID: 38470360
[TBL] [Abstract] [Full Text] [Related]
10. [The 504th case: Multiple lymph node enlargement, renal insufficiency, blindness, and white matter lesions of the brain].
Wei C; Zhuang Z; Li YL; Shi XX; Wen YB; Cao W; Fan SY; Zhang X; Zhang Y; Zhang W; Zhou DB
Zhonghua Nei Ke Za Zhi; 2024 Mar; 63(3):316-320. PubMed ID: 38448196
[TBL] [Abstract] [Full Text] [Related]
11. Immunocytokines with target cell-restricted IL-15 activity for treatment of B cell malignancies.
Zekri L; Hagelstein I; Märklin M; Klimovich B; Christie M; Lindner C; Kämereit S; Prakash N; Müller S; Stotz S; Maurer A; Greve C; Schmied B; Atar D; Rammensee HG; Jung G; Salih HR
Sci Transl Med; 2024 Mar; 16(737):eadh1988. PubMed ID: 38446900
[TBL] [Abstract] [Full Text] [Related]
12. Evaluation of mortality, prognostic parameters, and treatment efficacy in mycosis fungoides.
Porkert S; Griss J; Hudelist-Venz M; Steiner I; Valencak J; Weninger W; Brunner PM; Jonak C
J Dtsch Dermatol Ges; 2024 Apr; 22(4):532-550. PubMed ID: 38444271
[TBL] [Abstract] [Full Text] [Related]
13. Relevance of cd20 antigen expression among paediatric patients with B-lineage acute lymphoblastic leukaemia.
Bommannan K; Arumugam JR; Radhakrishnan V; Sundersingh S
Br J Haematol; 2024 Apr; 204(4):1367-1374. PubMed ID: 38444113
[TBL] [Abstract] [Full Text] [Related]
14. A human lymphoma organoid model for evaluating and targeting the follicular lymphoma tumor immune microenvironment.
Kastenschmidt JM; Schroers-Martin JG; Sworder BJ; Sureshchandra S; Khodadoust MS; Liu CL; Olsen M; Kurtz DM; Diehn M; Wagar LE; Alizadeh AA
Cell Stem Cell; 2024 Mar; 31(3):410-420.e4. PubMed ID: 38402619
[TBL] [Abstract] [Full Text] [Related]
15. Carnosic Acid against Lung Cancer: Induction of Autophagy and Activation of Sestrin-2/LKB1/AMPK Signalling.
O'Neill EJ; Sze NSK; MacPherson REK; Tsiani E
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396629
[TBL] [Abstract] [Full Text] [Related]
16. Sestrin 2 protects human lens epithelial cells from oxidative stress and apoptosis induced by hydrogen peroxide by regulating the mTOR/Nrf2 pathway.
Tian X; Wei J
Int J Immunopathol Pharmacol; 2024; 38():3946320241234741. PubMed ID: 38379215
[TBL] [Abstract] [Full Text] [Related]
17. Update on the management of relapsed/refractory chronic lymphocytic leukemia.
Bennett R; Seymour JF
Blood Cancer J; 2024 Feb; 14(1):33. PubMed ID: 38378673
[TBL] [Abstract] [Full Text] [Related]
18. The influence of cytotoxic drugs on the immunophenotype of blast cells in paediatric B precursor acute lymphoblastic leukaemia.
Prelog T; Bucek S; Brozic A; Peterlin J; Kavcic M; Omerzel M; Markelc B; Jesenko T; Prevodnik VK
Radiol Oncol; 2024 Mar; 58(1):133-144. PubMed ID: 38378030
[TBL] [Abstract] [Full Text] [Related]
19. Serologic Response to Vaccine for COVID-19 in Patients with Hematologic Malignancy: A Prospective Cohort Study.
Hillyer A; Quint A; Ghassemian A; Joh-Carnella N; Knauer MJ; Dawd D; Lazo-Langner A; Mangel J; Lam S; Abdoh H; Xenocostas A; Deotare U; Saini L; Foster C; Louzada M; Ho J; Chin-Yee I; Phua CW
Clin Lymphoma Myeloma Leuk; 2024 May; 24(5):305-315. PubMed ID: 38336492
[TBL] [Abstract] [Full Text] [Related]
20. Case report: Ensitrelvir for treatment of persistent COVID-19 in lymphoma patients: a report of two cases.
Furuya C; Yasuda H; Hiki M; Shirane S; Yamana T; Uchimura A; Inano T; Takaku T; Hamano Y; Ando M
Front Immunol; 2024; 15():1287300. PubMed ID: 38333218
[TBL] [Abstract] [Full Text] [Related]
[Next]
